Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 10 (October)

1. A 2-year naturalistic study on cognitive functioning in bipolar disorder.
   Acta Psychiatr Scand. [Abstract] [Full-text]
2. L-type calcium channels and psychiatric disorders: A brief review.
   Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
3. European collaborative study of early-onset bipolar disorder: Evidence for genetic heterogeneity on 2q14 according to age at onset.
   Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
4. Effects of severe mental illness on survival of people with diabetes.
   Br J Psychiatry, 197(4): 272-7. [Abstract] [Full-text]
5. Kraepelin Was Right: A Latent Class Analysis of Symptom Dimensions in Patients and Controls.
   Schizophr Bull. [Abstract] [Full-text]
6. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder.
   Int J Neuropsychopharmacol, 13(10): 1355-68. [Abstract] [Full-text]
7. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review.
   Int Psychogeriatr, 22(7): 1025-39. [Abstract] [Full-text]
8. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.
   Int J Neuropsychopharmacol, 13(10): 1369-81. [Abstract] [Full-text]
9. Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses.
   Int J Neuropsychopharmacol, 13(10): 1397-410. [Abstract] [Full-text]
10. How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers.
    Biol Psychiatry, 68(8): 733-40. [Abstract] [Full-text]
11. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
    Am J Psychiatry, 167(10): 1254-63. [Abstract] [Full-text]
12. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.
    Am J Psychiatry, 167(10): 1194-201. [Abstract] [Full-text]
13. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Int J Dev Neurosci. [Abstract] [Full-text]
14. A review of empirically supported psychological therapies for mood disorders in adults.
    Depress Anxiety, 27(10): 891-932. [Abstract] [Full-text]
15. Access-related measures and out-of-system utilization among veterans with bipolar disorder.
    Psychiatr Serv, 61(10): 1035-8. [Abstract] [Full-text]
16. Assault and mental disorders: a cross-sectional study of urban adult primary care patients.
    Psychiatr Serv, 61(10): 1018-23. [Abstract] [Full-text]
17. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
    Schizophr Res. [Abstract] [Full-text]
18. Prolidase activity and its diagnostic performance in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
19. Diet quality in bipolar disorder in a population-based sample of women.
    J Affect Disord. [Abstract] [Full-text]
20. Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
21. Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: The GAMIAN-Europe study.
    J Affect Disord. [Abstract] [Full-text]
22. The Neuroproteomics of Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
23. Continuity and cascade in offspring of bipolar parents: a longitudinal study of externalizing, internalizing, and thought problems.
    Dev Psychopathol, 22(4): 849-66. [Abstract] [Full-text]
24. Long-term results of surgery for lithium-associated hyperparathyroidism.
    Br J Surg, 97(11): 1680-5. [Abstract] [Full-text]
25. Continuity and cascade in offspring of bipolar parents: a longitudinal study of externalizing, internalizing, and thought problems.
    Dev Psychopathol, 22(4): 849-66. [Abstract] [Full-text]
26. Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses.
    Int J Neuropsychopharmacol, 13(10): 1397-410. [Abstract] [Full-text]
27. Long-term results of surgery for lithium-associated hyperparathyroidism.
    Br J Surg, 97(11): 1680-5. [Abstract] [Full-text]
28. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.
    Int J Neuropsychopharmacol, 13(10): 1369-81. [Abstract] [Full-text]
29. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review.
    Int Psychogeriatr, 22(7): 1025-39. [Abstract] [Full-text]
30. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder.
    Int J Neuropsychopharmacol, 13(10): 1355-68. [Abstract] [Full-text]
31. Gabapentin and suicide attempts.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
32. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    J Clin Psychiatry. [Abstract] [Full-text]
33. Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder.
    J Clin Psychiatry. [Abstract] [Full-text]
34. Effects of Early Intervention on the Course of Bipolar Disorder: Theories and Realities.
    Curr Psychiatry Rep. [Abstract] [Full-text]
35. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
    Mol Psychiatry. [Abstract] [Full-text]
36. Mobile interventions for severe mental illness: design and preliminary data from three approaches.
    J Nerv Ment Dis, 198(10): 715-21. [Abstract] [Full-text]
37. Effect of Mental Health Courts on Arrests and Jail Days: A Multisite Study.
    Arch Gen Psychiatry. [Abstract] [Full-text]
38. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
39. Age-related changes in the corpus callosum in early-onset bipolar disorder assessed using volumetric and cross-sectional measurements.
    Brain Imaging Behav, 4(3): 220-31. [Abstract] [Full-text]
40. Age-related changes in the corpus callosum in early-onset bipolar disorder assessed using volumetric and cross-sectional measurements.
    Brain Imaging Behav, 4(3): 220-31. [Abstract] [Full-text]
41. Age-related changes in the corpus callosum in early-onset bipolar disorder assessed using volumetric and cross-sectional measurements.
    Brain Imaging Behav, 4(3): 220-31. [Abstract] [Full-text]
42. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Alcohol Clin Exp Res, 34(10): 1822-31. [Abstract] [Full-text]
43. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring.
    J Dev Behav Pediatr, 31(8): 641-8. [Abstract] [Full-text]
44. Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder.
    Int Clin Psychopharmacol, 25(6): 323-7. [Abstract] [Full-text]
45. Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder.
    Int Clin Psychopharmacol, 25(6): 323-7. [Abstract] [Full-text]
46. Effectiveness of Maintenance Electroconvulsive Therapy in Rapid-Cycling Bipolar Disorder.
    J ECT. [Abstract] [Full-text]
47. Complicated Management of Mania in the Setting of Undiagnosed Obstructive Sleep Apnea.
    J ECT. [Abstract] [Full-text]
48. The genotoxic and oxidative damage potential of olanzapine in vitro.
    Toxicol Ind Health, 26(9): 583-8. [Abstract] [Full-text]
49. Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats.
    Eur J Pharmacol. [Abstract] [Full-text]
50. Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use.
    PLoS One, 5(9). [Abstract] [Full-text]
51. Disruption of White Matter Integrity in Bipolar Depression as a Possible Structural Marker of Illness.
    Biol Psychiatry. [Abstract] [Full-text]
52. Estimation of rac-Amisulpride Transfer into Milk and of Infant Dose via Milk During Its Use in a Lactating Woman with Bipolar Disorder and Schizophrenia.
    Breastfeed Med. [Abstract] [Full-text]
53. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
    Cancer Epidemiol Biomarkers Prev, 19(10): 2582-9. [Abstract] [Full-text]
54. Prolonged delirium after quetiapine overdose.
    Pediatr Emerg Care, 26(10): 754-6. [Abstract] [Full-text]
55. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
    J Psychiatr Res, 44(14): 903-9. [Abstract] [Full-text]
56. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    J Psychiatr Res, 44(14): 921-9. [Abstract] [Full-text]
57. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.
    J Psychiatr Res, 44(14): 971-8. [Abstract] [Full-text]
58. DSM-IV depressive symptom expression among individuals with a history of hypomania: a comparison to those with or without a history of mania.
    J Psychiatr Res, 44(14): 979-85. [Abstract] [Full-text]
59. Identification of high risk DISC1 protein structural variants in patients with bipolar spectrum disorder.
    Neurosci Lett. [Abstract] [Full-text]
60. Reelin as a putative vulnerability factor for depression: Examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice.
    Neuropharmacology. [Abstract] [Full-text]
61. High content analysis of histone acetylation in human cells and tissues.
    J Neurosci Methods, 193(1): 54-61. [Abstract] [Full-text]
62. Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.
    BMC Psychiatry, 10: 74. [Abstract] [Full-text]
63. Use of psychiatric inpatient capacities and diagnostic practice in Tashkent/Uzbekistan as compared to Berlin/Germany.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
64. The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies.
    Curr Psychiatry Rep. [Abstract] [Full-text]
65. Young rural people at risk for schizophrenia: time for mental health services to translate research evidence into best practice of care.
    Aust N Z J Psychiatry, 44(10): 872-82. [Abstract] [Full-text]
66. High content analysis of histone acetylation in human cells and tissues.
    J Neurosci Methods, 193(1): 54-61. [Abstract] [Full-text]
67. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys.
    Mol Psychiatry. [Abstract] [Full-text]
68. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
    Eur Arch Psychiatry Clin Neurosci, 260(7): 553-60. [Abstract] [Full-text]
69. Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case-Control Study.
    J Invest Dermatol. [Abstract] [Full-text]
70. Sport psychiatry: a systematic review of diagnosis and medical treatment of mental illness in athletes.
    Sports Med, 40(11): 961-80. [Abstract] [Full-text]
71. Sport psychiatry: a systematic review of diagnosis and medical treatment of mental illness in athletes.
    Sports Med, 40(11): 961-80. [Abstract] [Full-text]
72. Fronto-temporal spontaneous resting state functional connectivity in pediatric bipolar disorder.
    Biol Psychiatry, 68(9): 839-46. [Abstract] [Full-text]
73. Scopolamine produces larger antidepressant and antianxiety effects in women than in men.
    Neuropsychopharmacology, 35(12): 2479-88. [Abstract] [Full-text]
74. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.
    Biol Psychiatry, 68(9): 785-94. [Abstract] [Full-text]
75. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.
    Biol Psychiatry, 68(9): 801-10. [Abstract] [Full-text]
76. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study.
    J Affect Disord. [Abstract] [Full-text]
77. Fronto-temporal spontaneous resting state functional connectivity in pediatric bipolar disorder.
    Biol Psychiatry, 68(9): 839-46. [Abstract] [Full-text]
78. Scopolamine produces larger antidepressant and antianxiety effects in women than in men.
    Neuropsychopharmacology, 35(12): 2479-88. [Abstract] [Full-text]
79. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.
    Biol Psychiatry, 68(9): 785-94. [Abstract] [Full-text]
80. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.
    Biol Psychiatry, 68(9): 801-10. [Abstract] [Full-text]
81. Impact of psychiatric and social characteristics on HIV sexual risk behavior in Puerto Rican women with severe mental illness.
    Soc Psychiatry Psychiatr Epidemiol, 45(11): 1043-54. [Abstract] [Full-text]
82. An approach to the patient with dysregulated mood: major depression and bipolar disorder.
    Med Clin North Am, 94(6): 1117-26, x. [Abstract] [Full-text]
83. Cross-sectional and longitudinal relations between affective instability and depression.
    J Affect Disord. [Abstract] [Full-text]
84. Dysbindin (DTNBP1) - A role in psychotic depression?
    J Psychiatr Res. [Abstract] [Full-text]
85. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls.
    J Psychiatr Res. [Abstract] [Full-text]
86. Cerebellar hyperactivity during smooth pursuit eye movements in bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
87. Asenapine: A Review of Acute and Extension Phase Data in Bipolar Disorder.
    CNS Neurosci Ther. [Abstract] [Full-text]
88. An approach to the patient with dysregulated mood: major depression and bipolar disorder.
    Med Clin North Am, 94(6): 1117-26, x. [Abstract] [Full-text]
89. Impact of psychiatric and social characteristics on HIV sexual risk behavior in Puerto Rican women with severe mental illness.
    Soc Psychiatry Psychiatr Epidemiol, 45(11): 1043-54. [Abstract] [Full-text]
90. Gender differences in outcomes of acute mania: a 12-month follow-up study.
    Arch Womens Ment Health. [Abstract] [Full-text]
91. Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions.
    Neuropsychiatr Dis Treat, 6: 627-31. [Abstract] [Full-text]
92. Influence of psychiatric comorbidity on surgical mortality.
    Arch Surg, 145(10): 947-53. [Abstract] [Full-text]
93. 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
94. The psychiatric GWAS consortium: big science comes to psychiatry.
    Neuron, 68(2): 182-6. [Abstract] [Full-text]
95. Reasons for substance use among adolescents with bipolar disorder.
    Am J Addict, 19(6): 474-80. [Abstract] [Full-text]
96. Reasons for substance use among adolescents with bipolar disorder.
    Am J Addict, 19(6): 474-80. [Abstract] [Full-text]
97. Psychiatric comorbidity in patients with epilepsy: a population-based study.
    Eur J Clin Pharmacol, 66(11): 1151-60. [Abstract] [Full-text]
98. Prospective memory deficits in patients with bipolar disorder: a preliminary study.
    Arch Clin Neuropsychol, 25(7): 640-7. [Abstract] [Full-text]
99. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study.
    BMC Psychiatry, 10: 77. [Abstract] [Full-text]
100. Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene-Environment Interactions.
     CNS Neurosci Ther. [Abstract] [Full-text]
101. Prospective memory deficits in patients with bipolar disorder: a preliminary study.
     Arch Clin Neuropsychol, 25(7): 640-7. [Abstract] [Full-text]
102. Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R).
     Mol Psychiatry, 15(11): 1075-87. [Abstract] [Full-text]
103. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
     Mol Psychiatry, 15(11): 1101-11. [Abstract] [Full-text]
104. Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder.
     Psychoneuroendocrinology, 35(10): 1565-72. [Abstract] [Full-text]
105. Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study.
     Schizophr Res. [Abstract] [Full-text]
106. Standards of lithium monitoring in mental health trusts in the UK.
     BMC Psychiatry, 10: 80. [Abstract] [Full-text]
107. Brain size and brain/intracranial volume ratio in major mental illness.
     BMC Psychiatry, 10: 79. [Abstract] [Full-text]
108. Mental health stability in veterans with posttraumatic stress disorder receiving varenicline.
     Am J Health Syst Pharm, 67(21): 1832-7. [Abstract] [Full-text]
109. Temperament and character in patients with bipolar II disorder and recurrent brief depression.
     Compr Psychiatry, 51(6): 607-17. [Abstract] [Full-text]
110. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome.
     Compr Psychiatry, 51(6): 599-602. [Abstract] [Full-text]
111. ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.
     J Psychiatry Neurosci. [Abstract] [Full-text]
112. Mental health stability in veterans with posttraumatic stress disorder receiving varenicline.
     Am J Health Syst Pharm, 67(21): 1832-7. [Abstract] [Full-text]
113. Temperament and character in patients with bipolar II disorder and recurrent brief depression.
     Compr Psychiatry, 51(6): 607-17. [Abstract] [Full-text]
114. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome.
     Compr Psychiatry, 51(6): 599-602. [Abstract] [Full-text]
115. ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.
     J Psychiatry Neurosci. [Abstract] [Full-text]
116. Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder.
     Psychoneuroendocrinology, 35(10): 1565-72. [Abstract] [Full-text]
117. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
     Mol Psychiatry, 15(11): 1101-11. [Abstract] [Full-text]
118. Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R).
     Mol Psychiatry, 15(11): 1075-87. [Abstract] [Full-text]
119. Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome.
     J Psychiatr Res, 44(15): 1082-7. [Abstract] [Full-text]
120. Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder.
     J Psychiatr Res, 44(15): 1106-10. [Abstract] [Full-text]
121. Analysis of the GAD1 promoter: Trans-acting factors and DNA methylation converge on the 5' untranslated region.
     Neuropharmacology. [Abstract] [Full-text]
122. Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson disease.
     Parkinsonism Relat Disord. [Abstract] [Full-text]
123. TAAR6 variations possibly associated with antidepressant response and suicidal behavior.
     Psychiatry Res, 180(1): 20-4. [Abstract] [Full-text]
124. Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder.
     J Psychiatr Res, 44(15): 1106-10. [Abstract] [Full-text]
125. The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder.
     Psychiatry Res, 180(1): 54-6. [Abstract] [Full-text]
126. Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome.
     J Psychiatr Res, 44(15): 1082-7. [Abstract] [Full-text]
127. TAAR6 variations possibly associated with antidepressant response and suicidal behavior.
     Psychiatry Res, 180(1): 20-4. [Abstract] [Full-text]
128. The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder.
     Psychiatry Res, 180(1): 54-6. [Abstract] [Full-text]
129. Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities.
     PLoS One, 5(10): e13447. [Abstract] [Full-text]
130. Functional MRI of sustained attention in bipolar mania.
     Mol Psychiatry. [Abstract] [Full-text]
131. Psychometric properties of a scale to measure investment in the sick role: the Illness Cognitions Scale.
     J Eval Clin Pract. [Abstract] [Full-text]
132. Rapid quetiapine loading in youths with bipolar disorder.
     J Child Adolesc Psychopharmacol, 20(5): 441-5. [Abstract] [Full-text]
133. A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder.
     J Child Adolesc Psychopharmacol, 20(5): 395-406. [Abstract] [Full-text]
134. Functional MRI of sustained attention in bipolar mania.
     Mol Psychiatry. [Abstract] [Full-text]
135. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia.
     Psychiatr Genet, 20(6): 289-97. [Abstract] [Full-text]
136. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia.
     Psychiatr Genet, 20(6): 289-97. [Abstract] [Full-text]
137. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia.
     Psychiatr Genet, 20(6): 289-97. [Abstract] [Full-text]
138. The role and impact of contextual factors on functioning in patients with bipolar disorder.
     Disabil Rehabil, 32: S94-S104. [Abstract] [Full-text]
139. Epidemiologic study of aripiprazole use and the incidence of suicide events.
     Pharmacoepidemiol Drug Saf, 19(11): 1124-30. [Abstract] [Full-text]
140. Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
     Expert Rev Neurother, 10(11): 1637-58. [Abstract] [Full-text]
141. Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
     Expert Rev Neurother, 10(11): 1637-58. [Abstract] [Full-text]
142. Epidemiologic study of aripiprazole use and the incidence of suicide events.
     Pharmacoepidemiol Drug Saf, 19(11): 1124-30. [Abstract] [Full-text]
143. Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.
     J Sleep Res, 19(4): 516-24. [Abstract] [Full-text]
144. A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives.
     Psychol Med, 40(12): 2025-35. [Abstract] [Full-text]
145. Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.
     J Sleep Res, 19(4): 516-24. [Abstract] [Full-text]
146. A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives.
     Psychol Med, 40(12): 2025-35. [Abstract] [Full-text]
147. Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.
     J Sleep Res, 19(4): 516-24. [Abstract] [Full-text]
148. A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives.
     Psychol Med, 40(12): 2025-35. [Abstract] [Full-text]
149. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
     J Thromb Haemost, 8(10): 2182-91. [Abstract] [Full-text]
150. Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials.
     Neuropsychopharmacology. [Abstract] [Full-text]
151. Differential Responses to Emotional Interference in Paranoid Schizophrenia and Bipolar Mania.
     Psychopathology, 44(1): 1-11. [Abstract] [Full-text]
152. Differential Responses to Emotional Interference in Paranoid Schizophrenia and Bipolar Mania.
     Psychopathology, 44(1): 1-11. [Abstract] [Full-text]
153. The link between bipolar disorders and creativity: evidence from personality and temperament studies.
     Curr Psychiatry Rep, 12(6): 522-30. [Abstract] [Full-text]
154. Effects of early intervention on the course of bipolar disorder: theories and realities.
     Curr Psychiatry Rep, 12(6): 490-8. [Abstract] [Full-text]
155. Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.
     Curr Psychiatry Rep, 12(6): 512-21. [Abstract] [Full-text]
156. New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions.
     Curr Psychiatry Rep, 12(6): 505-11. [Abstract] [Full-text]
157. The bipolar spectrum: myth or reality?
     Curr Psychiatry Rep, 12(6): 479-89. [Abstract] [Full-text]
158. Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder.
     Curr Psychiatry Rep, 12(6): 499-504. [Abstract] [Full-text]
159. A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.
     Community Ment Health J, 46(6): 540-52. [Abstract] [Full-text]
160. The link between bipolar disorders and creativity: evidence from personality and temperament studies.
     Curr Psychiatry Rep, 12(6): 522-30. [Abstract] [Full-text]
161. Effects of early intervention on the course of bipolar disorder: theories and realities.
     Curr Psychiatry Rep, 12(6): 490-8. [Abstract] [Full-text]
162. Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.
     Curr Psychiatry Rep, 12(6): 512-21. [Abstract] [Full-text]
163. New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions.
     Curr Psychiatry Rep, 12(6): 505-11. [Abstract] [Full-text]
164. The bipolar spectrum: myth or reality?
     Curr Psychiatry Rep, 12(6): 479-89. [Abstract] [Full-text]
165. Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder.
     Curr Psychiatry Rep, 12(6): 499-504. [Abstract] [Full-text]
166. A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.
     Community Ment Health J, 46(6): 540-52. [Abstract] [Full-text]
167. The link between bipolar disorders and creativity: evidence from personality and temperament studies.
     Curr Psychiatry Rep, 12(6): 522-30. [Abstract] [Full-text]
168. Effects of early intervention on the course of bipolar disorder: theories and realities.
     Curr Psychiatry Rep, 12(6): 490-8. [Abstract] [Full-text]
169. Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.
     Curr Psychiatry Rep, 12(6): 512-21. [Abstract] [Full-text]
170. New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions.
     Curr Psychiatry Rep, 12(6): 505-11. [Abstract] [Full-text]
171. The bipolar spectrum: myth or reality?
     Curr Psychiatry Rep, 12(6): 479-89. [Abstract] [Full-text]
172. Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder.
     Curr Psychiatry Rep, 12(6): 499-504. [Abstract] [Full-text]
173. A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.
     Community Ment Health J, 46(6): 540-52. [Abstract] [Full-text]
174. Psychometric Properties of the Spanish Version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in Patients with Severe Mental Disorders.
     J Sex Med. [Abstract] [Full-text]
175. Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review.
     Pharmacopsychiatry. [Abstract] [Full-text]
176. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
     Int Clin Psychopharmacol. [Abstract] [Full-text]
177. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.
     J Affect Disord. [Abstract] [Full-text]
178. Structural Magnetic Resonance Imaging in Bipolar Disorder: An International Collaborative Mega-Analysis of Individual Adult Patient Data.
     Biol Psychiatry. [Abstract] [Full-text]
179. Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review.
     Pharmacopsychiatry. [Abstract] [Full-text]
180. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.
     J Affect Disord. [Abstract] [Full-text]
181. Structural Magnetic Resonance Imaging in Bipolar Disorder: An International Collaborative Mega-Analysis of Individual Adult Patient Data.
     Biol Psychiatry. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.